Table 4.

Type and Duration of Systemic Anticoagulation

	N=95	%
Patients who did not received any type of anticoagulation (AC)	22	23
Patients who received Systemic AC	73	76
Only Short Term AC	28	29
Only Long Term AC	34	36
Both Short and Long Term AC	11	12
Short Term AC used (<1 month), mean duration (6d)	N=39	41
LMWH	34	36
UH	1	1
Fondaparinux	3	3
No short-term anticoagulation used	56	59
Long term AC agent used (>1 month), mean duration (5m)	N=45	47
LMWH	32	32
NOAC	23	24
Fondaparinux	1	1
Warfarin	1	1
No Long-term anticoagulation used	50	53
Patients using Antiplatelet
Aspirin	5	5
clopidrogel	11	12

LMWH= low molecular weight heparin

UH= unfractioned weight heparin

NOAC= novel oral anticoagulant (apixaban, dabigatran, rivaroxaban)